MACEPHIN FORTE

This brand name is authorized in Nigeria.

Active ingredients

The drug MACEPHIN FORTE contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII 023Z5BR09K - CEFTRIAXONE SODIUM
 

Ceftriaxone is an antibacterial for systemic use, a third-generation cephalosporin. It inhibits bacterial cell wall synthesis following attachment to penicillin binding proteins (PBPs) leading to bacterial cell lysis and death.

 
Read more about Ceftriaxone
2
UNII DKQ4T82YE6 - SULBACTAM SODIUM
 
Read more about Sulbactam

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
A4-101145 Powder for injection Macephin Forte Injection INJ_PWD 1000 mg; 500 mg 1 x 1's (in vials) + 10 mL Sterilised WFI (in ampoules) Powder for injection NF-PP-390640 MACEPHIN FORTE INJECTION CEFTRIAXONE AND SULBACTAM FOR INJECTION 1.5GM AND STERILISED WATER FOR INJECTION BP 10ML CEFTRIAXONE & SULBACTAM FOR INJECTION 1.5 GM AND STERILISED WATER FOR INJECTIONS BP 10ML,SULBACTAM 500MG,CEFTRIAXONE 1 GM. Drugs Imported Products 1X10 WFI Prescription Only Medicine (POM) 11/20/2023 MALVEN MEDICS INTERNATIONAL COMPANY LTD, WILMER STREET, ILUPEJU ILUPEJU LAGOS 8037205003 malvenmedics@yahoo.com SWISS PARENTALS LIMITED, PLOT NO: 808,809 & 810 KERALA IN-INDUSTRIAL ESTATE, G.I.D.C, NEAR BAVLA, DISTRICT AHMEDABAD- 382220, GUJARAT, INDIA, India 30/01/2025

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database A4-101145

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.